Literature DB >> 2864496

Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes.

D Giugliano, A Ceriello, A Quatraro, F D'Onofrio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2864496     DOI： 10.1016/s0140-6736(85)90641-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 2.  Opioid peptides and glucose metabolism.

Authors:  A Lala; P Bouloux; G Tamburrano; E Gale
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

3.  Impaired insulin response to glucose but not to arginine in heroin addicts.

Authors:  N Passariello; D Giugliano; A Ceriello; A Chiariello; S Sgambato; F D'Onofrio
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

Review 4.  Opioid peptides and metabolic regulation.

Authors:  D Giugliano; R Torella; P J Lefèbvre; F D'Onofrio
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

5.  Morphine induces desensitization of insulin receptor signaling.

Authors:  Yu Li; Shoshana Eitan; Jiong Wu; Christopher J Evans; Brigitte Kieffer; Xiaojian Sun; Roberto D Polakiewicz
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Plasma beta-endorphin, free fatty acids and blood lipid changes in type 2 (non-insulin dependent) diabetic patients.

Authors:  S B Solerte; M Fioravanti; F Petraglia; F Facchinetti; A L Patti; N Schifino; A R Genazzani; E Ferrari
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

Review 7.  Effect of Opioid Use on Immune Activation and HIV Persistence on ART.

Authors:  Livio Azzoni; David Metzger; Luis J Montaner
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-25       Impact factor: 7.285
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.